An Emerging Markets Sponsored Commentary
And it’s simple. We like companies positioned in hot markets, with proven leadership and novel or proprietary technology, and revenue.
Collectively, these items suggest a greater probability for success.
But there is one other item that we are accepting is indicative of better stories, that we are adding to the EMR Outlook (more to come on that including an entry for non-toxic financing.)
The latest addition is independent and informed outside voices complementing or praising the Company’s product or technology.
We call it “The Expert’s View”. It’s a person or persons far more informed than we are on the specific subject matter and who has NOTHING to gain with their praise or adulation.
O.K. back to the story.
Over the years we have written ad nauseum about healthcare issues, knowing that the aging population in the country created an abundant need for innovation and profits in the sector. And over the past few years the advent of Artificial Intelligence has commanded our attention and led us to seek stories entrenched in the nexus of the aforementioned.
Well, here you go, an outstanding
And for those of you too lazy to click that link in ‘revenue’ we gift-wrapped above, the Company achieved revenue of
Just in Q3.
Got your attention?
You’re not alone.
Over the past few months Healwell has received praise and high praise from better voices in their industry, the aforementioned “Expert’s View” in our term of art.
A very recent release, one on the heels of some pretty good news for the Company’s future both financially and operationally, including truly significant M&A activity, lays it all out:
HEALWELL AI’s Pentavere Referenced by Several Leading Global Organizations for its Strength in Artificial Intelligence for Preventative Care
----- Source link.
An excerpt:
“In a recent report focused on AI in Health(1),
Look, you can go to a financial message board where a guy with ten shares yays or nays the stock while watching a split screen with his nightly Fortnite game.
Or we can turn our attention to the accolades of those who know the industry better and with no horse in the race.
Ultimately, it’s not just about what’s being said as it is who’s doing the talking.
About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by
For more informative reports such as this, please sign up at https://emergingmarketsconsulting.com/
Must Read OTC Markets/
- https://www.otcmarkets.com/learn/policy-on-stock-promotion
- https://www.otcmarkets.com/learn/investor-protection
- https://www.sec.gov/news/press-release/2017-79
- https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith,
(1) https://www.oecd.org/health/AI-in-health-huge-potential-huge-risks.pdf
(2) Vender, R. and
Emerging Markets Consulting, LLC
390 North Orange Ave STE 2300
E-mail: jamespainter@emergingmarketsllc.com
Web: https://emergingmarketsconsulting.com/
Source:
2024 GlobeNewswire, Inc., source